ThromboGenics planning offering

ThromboGenics N.V. (Euronext:THR) plans to sell up to 2.6 million shares in a private placement. If sold at ThromboGenics' close of EUR 16.90 on Monday, before the deal was announced, the company would raise EUR 44.6 million ($66.8 million). Petercam is sole global coordinator, with Jefferies and KBC acting as joint bookrunners. ThromboGenics was up EUR 0.22 on the day. ...